LY6K and esophageal squamous cell carcinoma: We generated an HLA-A2402-restricted, URLC10-specific CTL line from a healthy HLA-A2402-positive volunteer, in which URLC10 is an immunodominant peptide derived from CTA specific for ESCC (Suda et al, 2007).